Chemical Structure (Methylphenidate Hydrochloride Er Capsules 1)
Methylphenidate Hydrochloride Capsule, Extended Release
Product Images NDC 0406-1850
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Methylphenidate Hydrochloride (NDC 0406-1850). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Specgx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Pdp (Methylphenidate Hydrochloride Er Capsules 10)
This is a medication guide for NDC 0406-1860-01 containing 100 capsules of extended-release Methyiphenidate Hycloride USP with 60 mg potency. The package insert must be checked for dosage information and the capsules or beads inside must not be chewed or crushed. The storage temperature needs to be strictly maintained between 15° and 30°C, and the medication should be kept out of the reach of children. The product is manufactured by SpecGrl LLC and Mallinckrodt. The pharmacist should dispense the medication guide provided separately to each patient.*
Figure 1 (Methylphenidate Hydrochloride Er Capsules 2)
This text is a figure caption comparing the levels of methylphenidate in immediate-release and extended-release capsules after repeated doses in children with ADHD. The figure illustrates the mean levels of methylphenidate measured in nanograms per milliliter over time (up to 16 hours). The immediate-release capsule was administered at 0 and 4 hours to 21 participants, while the extended-release capsules were administered in two different doses (1 capsule and 2 capsules of 20mg each).*
Figure 2 (Methylphenidate Hydrochloride Er Capsules 3)
This is a figure showing the Least Squares Mean Change from Baseline in TCGIS Scores for Placebo and Methylphenidate HCI USP Extended-Release Capsules. The text provides the LS Mean Change from Baseline values in TCGIS Scores for both treatment groups.*
Figure 3 (Methylphenidate Hydrochloride Er Capsules 4)
The text describes figures 2 and 3 showing the LS Mean Change from Baseline in TCGIS Scores, Morning/Afternoon Groups for Methylphenidate HCI USP Extended-Release Capsules and Placebo groups. The figures were analyzed using the Last Observation Carried Forward method at week 3. The LS Mean Change from Baseline in TCGIS Scores was -10 for the groups. The standard error of the mean was represented using error bars.*
Pdp (Methylphenidate Hydrochloride Er Capsules 5)
NDC 0406-1810-01 is a medication containing Methylphenidate HCI in the form of extended-release capsules. The usual dosage is one capsule per day. This medication should be stored at controlled room temperature and kept out of reach of children. The medication guide should be dispensed to each patient along with the prescription. The text includes information on the manufacturer, Mallinckrodt, but the output is incomplete and contains some errors.*
Pdp (Methylphenidate Hydrochloride Er Capsules 6)
The text is describing a medication with the NDC code 0406-1820-01. Each capsule contains 20mg of Methylphenidate HCI, and it is an extended-release capsule with beads inside. The usual dosage is once daily. The medication is for prescription use only, and it is important to store it in a controlled room temperature and out of reach of children. The pharmacist should dispense the medication guide and provide it to each patient with a resistant container. The manufacturer is Spectx LLC, and it appears there is additional text related to Mallinckrodt™ and a code 10028 L90Y0.*
Pdp (Methylphenidate Hydrochloride Er Capsules 7)
The text is a medication label containing information about Methylphenidate Hydrochloride extended-release capsules. The medication comes in a bottle of 100 capsules, with each capsule containing 30mg of Methylphenidate Hydrochloride USP. The package insert should be consulted for dosage instructions. The medication guide should be provided to each patient, and the medication should be stored at room temperature. The medication should be kept out of reach of children. The manufacturer is Spece LLC.*
Pdp (Methylphenidate Hydrochloride Er Capsules 8)
This text is a description of a medication in the form of extended-release capsules containing Methylphenidate Hydrochloride. The medication is administered once daily and comes in a bottle of 100 capsules. The recommended dosage is not available. The storage recommendation is to keep the medication at room temperature and out of reach of children. The medication guide should be dispensed by the pharmacist to each patient. The manufacturer is SpecGrLLC, and the medication is distributed under the brand name Mallinckrodt.*
Pdp (Methylphenidate Hydrochloride Er Capsules 9)
This is a medication used once daily for the treatment of a medical condition. The medication is in capsule form and contains Methylphenidate HCI. The dosage information is available in the package insert and it should not be chewed or crushed. The medication should be stored at 25°C (77°F) with excursions permitted to 15°C to 30°C (55°F to 86°F). The manufacturer is SpecGr LLC located in Webster Groves, MO. This medication should be kept out of the reach of children and dispensed in a tight light-resistant container with a child-resistant closure.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
